Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Antios Therapeutics

Request full access

Innovative therapies to treat and cure hepatitis B virus (HBV) and other viral diseases

Atlanta, United StatesFounded 2018Biotech & Life Sciences

About Antios Therapeutics

Antios Therapeutics is a biopharmaceutical company focused on developing innovative therapies to treat and potentially cure hepatitis B virus (HBV) and other viral diseases. The company operates in the healthcare and pharmaceutical market, primarily targeting patients suffering from chronic HBV infections. Antios Therapeutics' core product includes ATI 2173, a novel compound combined with nucleoside analogues like Tenofovir or Entecavir, designed to inhibit HBV polymerase activity and viral replication. The company is also advancing its 4th generation capsid assembly modulator (CAM) program, which aims to enhance the immune system's ability to clear the virus more effectively. Antios Therapeutics generates revenue through the development and commercialization of its proprietary drug candidates, partnering with other biopharma companies for clinical trials and potential licensing agreements. The company serves a global market, addressing a significant unmet medical need with its cutting-edge antiviral therapies.

Source: Dealroom company data

At a glance

Founded
2018
Headquarters
Atlanta, United States
Sector
Biotech & Life Sciences

Antios Therapeutics in the Atlanta ecosystem

Live from Dealroom

The Antios Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

18 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A18 investors entered at this stage

  • Lumira Ventures
  • Domain Associates
  • Fonds de solidarité FTQ
  • CAM CAPITAL LIMITED
  • Delos Capital
  • Soleus Capital
  • Aisling Capital
  • Adage Capital
  • RA Capital Management
  • Altium Capital
  • Granite Point Capital
  • Pontifax Funds
  • LifeSci Venture Partners
  • Amzak Health Investors
  • CAM Capital
  • Sixty Degree Capital
  • EPIQ Capital Group
  • GordonMD Global Investment
Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Antios Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Antios Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.